| Stage | ABM | % of rev | ABNB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.3B | 100.00% | $3.6B | 100.00% | ABNB ×1.56 |
| Gross profit | $286M | 12.35% | $3.0B | 82.46% | ABNB +70.1pp |
| Operating income | $92M | 3.95% | $758M | 21.01% | ABNB +17.1pp |
| Pre-tax income | $63M | 2.73% | $897M | 24.86% | ABNB +22.1pp |
| Net income | $50M | 2.14% | $816M | 22.62% | ABNB +20.5pp |
| Stage | ABM | ABNB | Gap · A − B |
|---|---|---|---|
| Revenue | $2.3B100.00% | $3.6B100.00% | ABNB ×1.56 |
| Gross profit | 12.35%$286M | 82.46%$3.0B | ABNB +70.1pp |
| Operating income | 3.95%$92M | 21.01%$758M | ABNB +17.1pp |
| Pre-tax income | 2.73%$63M | 24.86%$897M | ABNB +22.1pp |
| Net income |
| 2.14%$50M |
| 22.62%$816M |
| ABNB +20.5pp |
No disclosed counterparties: ABNB.
None